10 can't-miss Houston business and innovation events for February

Where to be

Check out these workshops, networking events, pitch events, and other goings on in Houston this month. Getty Images

After what's felt like ages, 2019 has transitioned into a new month. For some, February means pink and red hearts. For Houstonians, it means the start of Rodeo Houston later this month. But, for entrepreneurs, the month yields a flurry of networking and professional events around town.

If you know of innovation-focused events for February, email me at natalie@innovationmap.com with the details.

February 5 - How to Start a Startup with Roberto Moctezuma, founder & CEO of Fractal River

Thinking 2019 is the year you finally turn your business idea into a startup? Station Houston wants to help. It's free to attend this discussion lead by Roberto Moctezuma, the founder and CEO of Houston-based Fractal River, an advisory firm. The talk will focus on identifying problems, determining market needs, learning important metrics, and more.

The event is from 5:30 to 6:30 pm on Tuesday, February 5, at Station Houston (1301 Fannin St., Suite 2440). Learn more here.

February 6 - SaaS Lifecycle Phase 3: Mapping Your Customer Journey

If you've got a SaaS-y startup, this is an event you can't miss. Blair Garrou of Mercury Fund will advise you on your company's sales, growth, and customer success. It's $10 to attend.

The event is from 12:30 to 2 pm on Wednesday, February 6, at Station Houston (1301 Fannin St., Suite 2440). Learn more here.

February 6 - Fruition Technology Labs Lunch n' Learn: Building Your Best Team

One of the main reasons startups fail is because of the people. Fruition Technology will offer their best advice for creating a solid team behind your startup.

The event is from 11:30 am to 1 pm on Wednesday, February 6, at The Cannon (1336 Brittmoore Road). Learn more here.

February 12 - Women Founders Series: Breaking Free of Impostor Syndrome

Calling all female entrepreneurs, women in business, and allies. Hear from a panel of women about their careers — both the ups and downs — and their advice for navigating the male-driven tech industry.

The event is from 11:30 am to 1 pm on Tuesday, February 12, at Station Houston (1301 Fannin St., Suite 2440). Learn more here.

February 12 - Women’s Masters Network Launch Party

Make your goals a reality at this women's professional networking event and launch party. The keynote speaker is Deidre Mathis.

The event is from 6 to 9 pm on Tuesday, February 12, at TXRX Labs (205 Roberts Street). Learn more here.

February 12 - The Global Startup with Innovation Norway

Nine Norwegian startups will pitch potential investors and collaborators at Station Houston's office in order to find for opportunities for international expansion. The Innovation Norway companies that will pitch are: CoreAll, Exebenus, Flapump, Geocap, Hammertech, Oliasoft, Pera, Solution Seeker, and Turbulent Flux.

The event is from 6 to 8 pm on Tuesday, February 12, at Station Houston (1301 Fannin St., Suite 2440). Learn more here.

February 13 - BBL Labs Energy Tech Accelerator Launch Party & Drone Demo

BBL Ventures is introducing BBL Labs, an energy tech accelerator program in partnership with Station Houston. Learn about the new program and network with energy tech professionals.

The event is from 6 to 9 pm on Wednesday, February 13, at Station Houston (1301 Fannin St., Suite 2440). Learn more here.

February 18 - NRLC Workshop: Pretotyping & Prototyping with Kara Palamountain

Figure out if your startup idea or product is needed and possible before you start investing your money and time in it at this workshop at Rice University. Featured speaker, Kara Palamountain, is a professor at the Kellogg School of Management and the president of the Northwestern Global Health Foundation.

The event is from 4 to 5:30 pm on Monday, February 18, at Liu Idea Lab for Innovation and Entrepreneurship (6100 Main St., Cambridge Office Building, Suite 130) Learn more here.

February 20 - Houston Blockchain Alliance Kickoff

New to the innovation scene, Houston Blockchain Alliance, a networking group of blockchain professionals, is celebrating its launch with a free event and panel discussion.

The kickoff celebration takes place from 5:30 to 8:30 pm on Wednesday, February 20, at the Houston CPA Society (777 Post Oak Blvd #500). Learn more here.

February 20 - InfoFluency Lunch n' Learn: Management Analytics for the Founder

If you're a founder who is evaluating or beginning use of a CRM, this one's for you. You'll get a basic understanding of the use of analytics in startup company management by attending the lunch and learn session.

The event is from 11:30 am to 1 pm on Wednesday, February 20, at The Cannon (1336 Brittmoore Road). Learn more here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings